UPDATE: Pfizer Posts Upbeat Q4 Results - Pfizer (NYSE:PFE)

Buy at this blue line for a shot at trading profitably

There are so many indicators out there on when to buy and sell. Nic uses none. He looks at a chart and buys when a stock “pushes” off this blue line. What blue line? Find out on the next page. It’ll change how you make money from stocks. Click here for the details.

Pfizer (NYSE: PFE) reported a rise in its fourth-quarter profit. Pfizer's quarterly profit surged to $6.3 billion, or $0.85 per share, versus $1.4 billion, or $0.19 per share, in the year-earlier period. Its adjusted profit came in at $0.47 per share. Its revenue dropped 7% to $15.07 billion. However, analysts were expecting earnings of $0.44 per share on revenue of $14.4 billion. Pfizer projects 2013 adjusted profit of $2.20 to $2.30 per share, versus analysts' estimates of $2.28 per share.Pfizer shares rose 0.52% to $26.98 in pre-market trading.

Buy at this blue line for a shot at trading profitably

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!